Maria May

Consejo Nacional De Investigaciones Científicas Y Técnicas, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Journal: British journal of cancer

Published: October 03, 2025

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression.

Journal: Oncotarget

Published: May 20, 2025

Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits.

Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits.

Journal: Science advances

Published: November 24, 2020

Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Journal: EBioMedicine

Published: September 08, 2020

Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.

Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.

Journal: Breast cancer research and treatment

Published: December 09, 2019

Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.

Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.

Journal: Hormones & cancer

Published: March 14, 2018

Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis.

Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis.

Journal: Current cancer drug targets

Published: July 13, 2017

Isoform specificity of progesterone receptor antibodies.

Isoform specificity of progesterone receptor antibodies.

Journal: The journal of pathology. Clinical research

Published: June 30, 2017

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.

Journal: Scientific reports

Published: November 11, 2016

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

Journal: Journal of the National Cancer Institute

Published: July 27, 2016

A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.

A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.

Journal: Journal of mammary gland biology and neoplasia

Published: June 15, 2016

Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer.

Nuclear staining of fgfr-2/stat-5 and runx-2 in mucinous breast cancer.

Journal: Experimental and molecular pathology

Published: October 21, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026